Differential Regulation of Luteinizing Hormone-Releasing Hormone and Galanin Messenger Ribonucleic Acid Levels by Alpha1Adrenergic Agents in the Ovariectomized Rat
- 1 June 1992
- journal article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 4 (3) , 331-336
- https://doi.org/10.1111/j.1365-2826.1992.tb00176.x
Abstract
α(1) -Adrenergic control of luteinizing hormone-releasing hormone (LHRH) and galanin mRNA levels was examined in ovariectomized rats. Each rat was ovariectomized and a permanent bilateral cannula was implanted 1 mm dorsal to the preoptic area. Eleven to 14 days later, each rat received one of three treatments: prazosin (α(1) antagonist, n = 8), methoxamine (α(1) agonist, n = 5) or control (no drug, n = 7). Each drug was suspended in a polyacrylamide gel matrix and delivered to the preoptic area via the bilateral cannula. After 24 h of continuous exposure to the adrenergic agents (or control), rats were anesthetized, decapitated and brains were stored in liquid nitrogen until sectioned (7 μm) on a cryostat. In situ hybridization was performed using a [(32) P]-end-labelled 59mer complementary to LHRH mRNA. Reduced silver grains, proportional to LHRH mRNA content, were quantified for number of LHRH cells per section, number of grains per labelled cell and total number of grains in labelled cells. Compared to the controls, prazosin caused a 32% decrease (P<0.05) in the number of cells expressing the LHRH gene. The LHRH cells from untreated animals had a median of 53 grains/cell with a smooth distribution above and below the median. Treatment with prazosin reduced the median number of grains/cell to 36 (P<0.05). When the number of grains in labelled cells were totalled, prazosin decreased (P<0.01) the number of grains by 47%. Surprisingly, methoxamine caused no quantitative changes in any of the parameters examined. This might be explained if LHRH transcription in control animals was proceeding at near-maximal rates supported, in part, by an endogenous α(1) ligand. Alternatively, continuous exposure to this agonist may have resulted in desensitization to its stimulatory effects. When anatomically matched brain tissue sections from these animals were examined for galanin mRNA, no differences among experimental groups were detected. In conclusion, administration of an α(1) -adrenergic antagonist into the preoptic area suppressed levels of LHRH mRNA but not galanin mRNA. Therefore, the data suggest that an endogenous α(1) ligand, such as norepinephrine (or epinephrine), is required to maintain a high level of LHRH gene expression in the ovariectomized rat.Keywords
This publication has 28 references indexed in Scilit:
- Colocalization of galanin and luteinizing hormone-releasing hormone in a subset of preoptic hypothalamic neurons: anatomical and functional correlates.Proceedings of the National Academy of Sciences, 1990
- Activation of intracellular pathways with forskolin and phorbol ester increases LHRH mRNA level in the rat hypothalamus superfused in vitroMolecular Brain Research, 1990
- Estradiol stimulates preoptic area-anterior hypothalamic proGnRH-GAP gene expression in ovariectomized ratsMolecular Brain Research, 1989
- In situ hybridization for LHRH mRNA following estrogen treatmentMolecular Brain Research, 1989
- In Situ Hybridization: A Methodological GuidePublished by Elsevier ,1989
- Tissue-specific expression of the rat galanin gene.Proceedings of the National Academy of Sciences, 1988
- Temporal pattern of HRP spread from an iontophoretic deposit site and description of a new HRP‐gel implant methodJournal of Comparative Neurology, 1984
- α1-Adrenergic receptor involvement in the LH surge in ovariectomized estrogen-primed ratsEuropean Journal of Pharmacology, 1982
- Distribution of α-adrenergic, β-adrenergic and dopaminergic receptors in discrete hypothalamic areas of ratBrain Research, 1982
- Noradrenergic alpha 1 and alpha 2 receptors: light microscopic autoradiographic localization.Proceedings of the National Academy of Sciences, 1980